Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals

The development of in vivo biomarkers of Alzheimer’s disease (AD) has advanced the diagnosis of AD from a clinical syndrome to a biological construct. The preclinical stage of AD continuum is defined by the identification of AD biomarkers crossing the pathological threshold in cognitively unimpaired...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kok Pin, Chiew, Hui, Rosa-Neto, Pedro, Kandiah, Nagaendran, Ismail, Zahinoor, Gauthier, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011383/
https://www.ncbi.nlm.nih.gov/pubmed/33789730
http://dx.doi.org/10.1186/s40035-021-00236-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011383/
https://www.ncbi.nlm.nih.gov/pubmed/33789730
http://dx.doi.org/10.1186/s40035-021-00236-3

Ejemplares similares